Role of Functional MRI in Liver SBRT: Current Use and Future Directions

Abstract

Stereotactic body radiation therapy (SBRT) is an emerging treatment for liver cancers whereby large doses of radiation can be delivered precisely to target lesions in 3–5 fractions. The target dose is limited by the dose that can be safely delivered to the non-tumour liver, which depends on the baseline liver functional reserve. Current liver SBRT guidelines assume uniform liver function in the non-tumour liver. However, the assumption of uniform liver function is false in liver disease due to the presence of cirrhosis, damage due to previous chemo- or ablative therapies or irradiation, and fatty liver disease. Anatomical information from magnetic resonance imaging (MRI) is increasingly being used for SBRT planning. While its current use is limited to the identification of target location and size, functional MRI techniques also offer the ability to quantify and spatially map liver tissue microstructure and function. This review summarises and discusses the advantages offered by functional MRI methods for SBRT treatment planning and the potential for adaptive SBRT workflows.

Genome-wide analyses of lung cancer after single high-dose radiation at five time points (2, 6, 12, 24, and 48 h)

“…In recent years, precision radiotherapy applied high-dose therapy (Burkoň et al, 2022;Chairmadurai et al, 2022;DLP et al, 2022;Milic et al, 2022;Sidaway, 2022;Tadimalla et al, 2022). Stereotactic body radiotherapy (SBRT) has the characteristics of high tumor dose distribution in the irradiation center and a rapid drop of extradural dose.…”